Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

2.97
Delayed Data
As of 3:59pm ET
 -0.01 / -0.34%
Today’s Change
1.50
Today|||52-Week Range
5.44
-3.26%
Year-to-Date

Today’s Trading

Previous close2.98
Today’s open2.99
Day’s range2.90 - 3.04
Volume951,185
Average volume (3 months)2,038,511
Market cap$285.7M
Dividend yield--
Data as of 3:59pm ET, 08/23/2016

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)+23.39%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-42.81%
P/E ratioNM
Price/Sales68.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TRIBTrinity Biotech PLC0.000.00%
LNTHLantheus Holdings In...-0.81-9.89%
OXFDOxford Immunotec Glo...-0.09-0.85%
CLDXCelldex Therapeutics...-0.12-3.08%
Data as of 4:00pm ET, 08/23/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$3.2M
Annual profit (last year)-$59.0M
Net profit margin-1,825.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts

Partner Offers

Search for Jobs